The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.

This study systematically elucidates the drug resistance mechanisms of five highly pathogenic viruses, proposes five ...

Long COVID—defined as symptoms persisting ≥ 2 months beyond acute SARS-CoV-2 infection without alternative explanation—now ...

NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) said interim results from a mid-stage clinical trial suggest its experimental COVID-19 treatment ratutrelvir may offer a differentiated alternative to ...

Long COVID has lingered as one of the most unsettling legacies of the pandemic, a condition that can derail lives long after ...

NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...

Scientists used a clinical-grade gum in experiments to "substantially" lower viral loads of two herpes simplex viruses and ...

The American Academy of Pediatrics updated its COVID-19 vaccination recommendations for preventing severe disease in infants, children, and adolescents.

Traws Pharma reports interim Phase 2 data showing ratutrelvir performed comparably to Paxlovid in mild-to-moderate COVID-19 patients.

NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine) ...

They came as the commander who launched the strike headed to brief lawmakers. New details emerged Wednesday about the second strike by the U.S. military on an alleged drug smuggling boat on Sept. 2 ...